- Home
- PTGX vs CWEN Comparison
PTGX vs CWEN Comparison
Compare PTGX & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- CWEN
- Stock Information
- Founded
- PTGX 2006
- CWEN 2012
- Country
- PTGX United States
- CWEN United States
- Employees
- PTGX 130
- CWEN N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- CWEN Electric Utilities: Central
- Sector
- PTGX Health Care
- CWEN Utilities
- Exchange
- PTGX Nasdaq
- CWEN Nasdaq
- Market Cap
- PTGX 5.0B
- CWEN 3.8B
- IPO Year
- PTGX 2016
- CWEN 2013
- Fundamental
- Price
- PTGX $79.54
- CWEN $34.94
- Analyst Decision
- PTGX Strong Buy
- CWEN Buy
- Analyst Count
- PTGX 9
- CWEN 6
- Target Price
- PTGX $86.22
- CWEN $37.17
- AVG Volume (30 Days)
- PTGX 1.3M
- CWEN 1.2M
- Earning Date
- PTGX 11-06-2025
- CWEN 11-04-2025
- Dividend Yield
- PTGX N/A
- CWEN 5.05%
- EPS Growth
- PTGX N/A
- CWEN 125.75
- EPS
- PTGX 0.72
- CWEN 2.34
- Revenue
- PTGX $209,217,000.00
- CWEN $1,375,000,000.00
- Revenue This Year
- PTGX N/A
- CWEN $5.03
- Revenue Next Year
- PTGX $140.23
- CWEN $13.19
- P/E Ratio
- PTGX $110.77
- CWEN $14.98
- Revenue Growth
- PTGX N/A
- CWEN 0.81
- 52 Week Low
- PTGX $33.31
- CWEN $24.40
- 52 Week High
- PTGX $93.25
- CWEN $35.20
- Technical
- Relative Strength Index (RSI)
- PTGX 62.21
- CWEN 74.87
- Support Level
- PTGX $75.44
- CWEN $32.08
- Resistance Level
- PTGX $80.43
- CWEN $35.20
- Average True Range (ATR)
- PTGX 2.61
- CWEN 0.93
- MACD
- PTGX -0.23
- CWEN 0.29
- Stochastic Oscillator
- PTGX 89.38
- CWEN 95.14
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.